| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 11.03. | Simris Group AB: Simis provides an update on the divestment of its assets in Hammenhög, Sweden | 80 | GlobeNewswire (Europe) | Simris Group AB ("Simris" or the "Company") announces that discussions with Immunrise Biocontrol France SAS ("Immunrise") continue, on a non-exclusive basis, beyond the deadline of March 1, 2026 and... ► Artikel lesen | |
| 28.02. | Simris Group AB: Simris Group Year-end Report January-december 2025 | 361 | GlobeNewswire (Europe) | QUARTER 4, JULY - DECEMBER 2025Net revenue decreased by 71% to SEK 285k (971k).EBITDA declined by 63% to SEK -5 196k (-3 180k).EBIT/Operating result improved by 9% to SEK -8 429 (-9 241k).YEAR-END PERIOD... ► Artikel lesen | |
| 19.01. | Simris Group AB: Bulletin from Simris Group AB's extraordinary general meeting | 227 | GlobeNewswire (Europe) | Simris Group AB (publ), reg. no. 556841-9187 (the "Company"), held an extraordinary general meeting on 19 January 2026. Below follows a summary of the resolutions that were passed at the general meeting.
Election... ► Artikel lesen | |
| 12.11.25 | Simris Group AB receives observation status | 183 | GlobeNewswire | Today, November 12, 2025, Simris Group AB (the "Company") disclosed its interim report for the third quarter of 2025 with information on the Company's financial situation.
The rules of Nasdaq... ► Artikel lesen | |
| SIMRIS GROUP Aktie jetzt für 0€ handeln | |||||
| 12.11.25 | Simris Group AB: Simris Group Interim Report January-september 2025 | 202 | GlobeNewswire (Europe) | QUARTER 3, JULY - SEPTEMBER 2025Net revenue decreased by 37% to SEK 484k (766k).EBITDA declined by 22% to SEK -3 639k (-2 971k).EBIT/Operating result declined by 8% to SEK -7 152k (-6 614k).INTERIM... ► Artikel lesen | |
| 10.11.25 | Simris Group AB: Simris Group announces leadership transition - Daniel Kubitza appointed interim CEO | 237 | GlobeNewswire (Europe) | The Board of Directors of Simris Group has appointed Daniel Kubitza as interim CEO, effective immediately.
Daniel Kubitza has over 20 years of experience in corporate financing, commercialization and... ► Artikel lesen | |
| 05.11.25 | Simris Group AB: Simris Group AB Announces Positive Results from Ongoing Antibody-Drug Conjugate (ADC) Study with Nuvisan | 214 | GlobeNewswire (Europe) | Simris Group AB's wholly owned subsidiary, Simris Biologics GmbH, today announced important progress in its ongoing preclinical study with Nuvisan, a leading European contract research and development... ► Artikel lesen | |
| 06.10.25 | Simris Group AB: Update Regarding In-Vitro Evaluation of Novel Advance Microcystin Payloads | 277 | GlobeNewswire (Europe) | Simris Group AB wholly owned subsidiary, Simris Biologics GmbH, today announced short technical delays in a previously announced study contracted with Nuvisan, a leading European contract research and... ► Artikel lesen | |
| 12.09.25 | Simris Group AB: Simris Biologics awarded €200K in non-dilutive funding for R&D programme to further develop microcystin payloads for Antibody Drug Conjugates (ADCs) | 914 | GlobeNewswire (Europe) | Simris Group AB, a pioneer in the development of novel, next-generation Antibody Drug Conjugate (ADC) payloads based on Microcystin (MC) toxin variants, announces that funding has been approved for... ► Artikel lesen | |
| 13.08.25 | Simris Group AB: Simris Group Interim Report January-june 2025 | 249 | GlobeNewswire (Europe) | QUARTER 2, APRIL - JUNE 2025Net revenue increased by 8% to SEK 687k (634k).EBITDA improved by 51% to SEK -2 980k (-6 117k).EBIT/Operating result improved by 32% to SEK -6 693k (-9 822k).INTERIM PERIOD... ► Artikel lesen | |
| 14.07.25 | Simris Group AB: Partner Company Decides Not to Proceed with Simris Group ADC Proposed Collaboration Following Strategic Review | 246 | GlobeNewswire (Europe) | Simris Group AB (publ), through its subsidiary Simris Biologics GmbH, announces that the EU-based biopharmaceutical company with which it had signed a non-binding concept sheet for a potential antibody-drug... ► Artikel lesen | |
| 28.05.25 | Simris Group AB: Bulletin from Simris Group AB's annual general meeting | 355 | GlobeNewswire (Europe) | Simris Group AB (publ), reg. no. 556841-9187 (the "Company"), held its annual general meeting on 28 May 2025. Below follows a summary of the resolutions that were passed at the general meeting.
Income... ► Artikel lesen | |
| 14.05.25 | Simris Group AB: Simris Group Interim Report January-march 2025 | 423 | GlobeNewswire (Europe) | QUARTER 1, JANUARY - MARCH 2025Net revenue decreased by 69 percent to SEK 159k (519k).EBITDA improved by 30 percent to SEK -3 724k (-5 325k). EBIT/ operating result improved by 19 percent to SEK -7... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BEYOND MEAT | 0,571 | +0,96 % | Opening Bell: SMA, Kontron, EQT Corp., Newmont, Micron, Worthington Steel, Beyond Meat, H&M, Inditex | Die US-Börsen haben am Mittwoch zugelegt. Der Dow Jones stieg 0,66 Prozent, der Nasdaq Composite gewann 0,77 Prozent. Für Auftrieb sorgte neue Zuversicht, dass es im Iran-Konflikt zu einer diplomatischen... ► Artikel lesen | |
| OATLY GROUP | 8,340 | -2,80 % | Future Market Insights, Inc.: Global Dairy Alternatives Market to Reach USD 51.9 Billion by 2036 as Europe Leads Adoption and Germany Dominates Growth; Danone, Oatly and SunOpta Inc. Accelerate Innovation | Asia-Pacific demand surge led by India and China, while Europe and North America strengthen retail and foodservice expansion of plant-based nutrition.NEWARK, Del., March 24, 2026 /PRNewswire/... ► Artikel lesen | |
| CONAGRA BRANDS | 13,446 | +1,34 % | UBS reiterates Neutral on ConAgra stock ahead of earnings | ||
| WINGSTOP | 144,00 | +5,88 % | Multiple Analysts Bullish on Wingstop Inc's (WING) Prospects | ||
| WH GROUP | 1,180 | +7,27 % | WH Group Limited Full Year Profit Declines | WASHINGTON (dpa-AFX) - WH Group Limited (WHGLY) announced earnings for full year that Dropped, from last yearThe company's bottom line came in at $1.567 billion, or $0.122 per share. This compares... ► Artikel lesen | |
| JACK IN THE BOX | 9,650 | +3,21 % | Jack in the Box: Aktionäre verlängern Schutzvereinbarung und bestätigen Verwaltungsrat | ||
| MHP | 6,450 | -1,53 % | MHP SE Strengthens Its Financial Position With U.S.$550 Million Issuance | KYIV, Ukraine, March 10, 2026 /PRNewswire/ -- MHP SE, a leading international food and agricultural group, announces the issuance of U.S.$550 million aggregate principal amount of 10.500% notes... ► Artikel lesen | |
| ELSE NUTRITION | 0,030 | -0,33 % | Else Nutrition Holdings Inc.: Else Nutrition Expected to Benefit from FDA Regulatory Progress on Infant Formula Protein Standards | Updated FDA Framework Bolsters Scientific Validation Pathway for Else's Plant-Based Formula and Accelerates U.S. Commercialization Potential
VANCOUVER, BC, March... ► Artikel lesen | |
| PP LONDON SUMATRA INDONESIA | 0,060 | +0,85 % | XFRA NEW INSTRUMENTS AVAILABLE ON 08.12.2025 | The following instruments on XETRA do have their first trading 08.12.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 08.12.2025
Aktien
1 KYG4600C1107 Hope Life International... ► Artikel lesen | |
| BIOGAIA | 10,840 | +0,84 % | BioGaia AB: BioGaia exercises option to acquire remaining shares in Nutraceutics | BioGaia exercises the option to acquire the remaining 20 percent of the shares in Nutraceutics, the parent company to BioGaia's exclusive distributor of BioGaia's own products in the USA.
BioGaia... ► Artikel lesen | |
| J&J SNACK FOODS | 68,00 | +0,74 % | Dividendenbekanntmachungen (17.03.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) 2020 BULKERS LTD BMG9156K1018 0,9713 NOK 0,0872 EUR ALK-ABELLO A/S DK0061802139 1,6 DKK 0,2141 EUR ARES MANAGEMENT CORPORATION US03990B1017 1... ► Artikel lesen | |
| CAVA GROUP | 75,45 | -4,24 % | Analyst Reassess CAVA Group (CAVA) As Company Launches First-ever Seafood Offering | ||
| NESTLE | 83,06 | -0,01 % | JEFFERIES stuft Nestle auf 'Hold' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat das Kursziel für Nestle von 77 auf 80 Franken angehoben, aber die Einstufung auf "Hold" belassen. Analyst David Hayes rechnet für das erste... ► Artikel lesen | |
| KURA SUSHI USA | 66,16 | -1,25 % | Kura Sushi stock rating reiterated by William Blair on sales outlook | ||
| GENERAL MILLS | 31,980 | +2,30 % | General Mills - GIS: Outside Reversal beim Lebensmittelhersteller! | Buy the Dip? Rutscht die General-Mills-Aktie (GIS) unter das Tief vom März 2018 bei 36.42 USD? Kommt HEUTE der technische Bounce? General Mills (GIS) - ISIN US3703341046 Rückblick: Rund um die Q3-Zahlen... ► Artikel lesen |